(EDOC) Global X Telemedicine & - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US37954Y2853 • Health
EDOC: Telemedicine, Digital Health, Healthcare
The index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of telemedicine and digital health, as well as applications thereof (collectively, Telemedicine & Digital Health Companies), as defined by Solactive AG, the provider of the index. The Adviser uses a passive or indexing approach to try to achieve the fund's investment objective. The fund is non-diversified.
Additional Sources for EDOC ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
EDOC ETF Overview
| Market Cap in USD | 38m |
| Category | Health |
| TER | 0.68% |
| IPO / Inception | 2020-07-29 |
EDOC ETF Ratings
| Growth 5y | -41.6% |
| Fundamental | - |
| Dividend | 1.0% |
| Rel. Strength Industry | -59.5 |
| Analysts | - |
| Fair Price Momentum | 9.79 USD |
| Fair Price DCF | - |
EDOC Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 1.0% |
EDOC Growth Ratios
| Growth Correlation 3m | 58.4% |
| Growth Correlation 12m | 52.3% |
| Growth Correlation 5y | -90.4% |
| CAGR 5y | -8.17% |
| CAGR/Mean DD 5y | -0.21 |
| Sharpe Ratio 12m | 0.35 |
| Alpha | -17.67 |
| Beta | 1.06 |
| Volatility | 22.74% |
| Current Volume | 15k |
| Average Volume 20d | 26k |
What is the price of EDOC stocks?
As of January 23, 2025, the stock is trading at USD 10.62 with a total of 15,000 shares traded.
Over the past week, the price has changed by +4.53%, over one month by +5.67%, over three months by +10.62% and over the past year by +10.86%.
As of January 23, 2025, the stock is trading at USD 10.62 with a total of 15,000 shares traded.
Over the past week, the price has changed by +4.53%, over one month by +5.67%, over three months by +10.62% and over the past year by +10.86%.
Is Global X Telemedicine & a good stock to buy?
Probably not. Based on ValueRay Analyses, Global X Telemedicine & (NASDAQ:EDOC) is currently (January 2025) not a good stock to buy. It has a ValueRay Growth Rating of -41.55 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EDOC as of January 2025 is 9.79. This means that EDOC is currently overvalued and has a potential downside of -7.82%.
Probably not. Based on ValueRay Analyses, Global X Telemedicine & (NASDAQ:EDOC) is currently (January 2025) not a good stock to buy. It has a ValueRay Growth Rating of -41.55 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EDOC as of January 2025 is 9.79. This means that EDOC is currently overvalued and has a potential downside of -7.82%.
Is EDOC a buy, sell or hold?
Global X Telemedicine & has no consensus analysts rating.
Global X Telemedicine & has no consensus analysts rating.
What are the forecast for EDOC stock price target?
According to ValueRays Forecast Model, EDOC Global X Telemedicine & will be worth about 10.9 in January 2026. The stock is currently trading at 10.62. This means that the stock has a potential upside of +2.73%.
According to ValueRays Forecast Model, EDOC Global X Telemedicine & will be worth about 10.9 in January 2026. The stock is currently trading at 10.62. This means that the stock has a potential upside of +2.73%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 10.9 | 2.7% |